Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: Post-hoc analysis of a randomised, placebo-controlled phase II clinical trial
There is as yet no visible hair loss
In clinical trials, patients on Tirzepatide lost up to 21% of body weight, compared to around 15% on Semaglutide, making it an attractive option for patients seeking more aggressive weight loss
Your card is securely saved while a licensed physician reviews your case, typically within 24 to 48 hours
US$ 28.89
US$ 26.31
US$ 21.44
![D-Ser11]-Tirzepatide](https://www.daicelpharmastandards.com/wp-content/uploads/2024/05/dcti-d-367.png)
US$ 28.27
US$ 29.65
